Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Warns Haemonetics Over Blood Collection Products - Medical Product Outsourcing

FDA Warns Haemonetics Over Blood Collection Products

The agency wants the company to have an outside audit.

The U.S. Food and Drug Administration issued a warning letter Dec. 4 to Haemonetics Corp., saying it failed to fix several manufacturing issues, including taking proper steps to ensure the quality of its blood collection products.

The Braintree, Mass.-based company, which manufactures devices and other products to collect and process blood, must have an outside expert audit its manufacturing and quality systems, the FDA said.

 FDA officials discovered the problems while inspecting the company’s Niles, Ill., plant in June and July. Haemonetic responded to the investigators’ concerns in late July, but the FDA found many of its steps to be unsatisfactory.

 Among the violations were Haemonetics’ not setting up quality control procedures for suppliers and contractors. It also did not properly create systems to ensure product standards, the letter said. 

Company representatives did not return requests for comment. 

Go to http://www.fda.gov/foi/warning_letters/s7060c.htm to view the warning letter.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters